# V3.20 exact implementation diff review — protected-base evidence closure

Date: 2026-08-30

Review authority: read-only examination of the complete immutable V3.20 range
and its production-bound test evidence. This review did not mutate production
data, runtime, scheduler, Vercel, source providers, LINE, dispatch, automatic
trading, Promotion, or evaluation governance.

Final verdict: `PASS`

Findings: `P0=0 P1=0 P2=0`

## Immutable subject

- Final reviewed repair/tree: `1b732a216b26dd15009e29a583521a373cf5f6cf` / `d5c5a15f6363f24f9d1793f6e2c96e737d294e94`
- Full final range: `7f461e74dc7d786a455106e20551df13d2c9131f..1b732a216b26dd15009e29a583521a373cf5f6cf`
- Active graph: `329de76e514164f7ebd1905708491aa15e80c9ce34eb0fb7be3eb03786cdcf64`

## Review result

- The complete protected-base range passes `git diff --check`. The final two
  binding commits are intentionally tree-identical to their parents; they bind
  immutable evidence to the external gate's protected merge-base and closed
  review schema without changing production behavior.
- The V3.20 retention bridge can recover only an immutable InvestAnchors
  ledger whose document and valid source-identity authority agree at the
  cutoff. It cannot revive official-market-factor, seed, peer, price, or
  unverified legacy nominations.
- KOL-first authority remains closed: only approved KOL material, authorized
  Threads, public Telegram, eligible Podcast/YouTube transcripts, structured
  InvestAnchors claims, or attested inbox claims may nominate. Official data
  remains verification-only, and entity joins require code plus company or
  context validation.
- Lost leases now become durable, closed diagnostics and activation rollback
  records persist only bounded reason/stage fields. No raw launchd output,
  SQL, URLs, provider payloads, credentials, roles, or internal exception text
  can enter runtime evidence.
- The reviewed tree passed typecheck, lint, production build, 63/63 core
  tests, 150/150 product-correctness tests including 31/31 PCR cases, 75/75
  migration tests with double apply, 2/2 legacy regressions, 9/9 Playwright
  tests, and 5/5 projection-performance tests. The final H12/H13 diagnostic
  delta also passed its 150/150 product-correctness rerun.
- Output remains research-only until verified official facts, valuation,
  technical authority, and runtime health exist. No target price or buy action
  is fabricated, and evaluation governance remains non-fabricated/blocked.

## Closure

No P0, P1, or P2 finding remains. This reviewed tree is ready for the normal
protected Code Gate, then the bounded runtime recovery and read-only production
verification.
